Pyxis Oncology Inc (PYXS) — Cash Flow-to-Debt Ratio
Pyxis Oncology Inc (PYXS) has a Cash Flow-to-Debt Ratio of -0.36x as of September 2025, meaning its operating cash flow of $-13.28 Million could theoretically repay 0% of its total liabilities ($36.83 Million) in one year. See how much free cash does Pyxis Oncology Inc generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pyxis Oncology Inc Cash Flow-to-Debt Ratio (2019–2024)
Historical debt coverage capacity for Pyxis Oncology Inc across 6 annual periods. Also explore Pyxis Oncology Inc (PYXS) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Pyxis Oncology Inc (2019–2024)
Year-by-year debt coverage analysis for Pyxis Oncology Inc. For market capitalisation and broader financial context, see Pyxis Oncology Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.58x | $-57.67 Million | $36.43 Million | ▼ -7.5% |
| 2023 | -1.47x | $-70.71 Million | $48.02 Million | ▲ +16.7% |
| 2022 | -1.77x | $-89.33 Million | $50.55 Million | ▲ +6.4% |
| 2021 | -1.89x | $-35.33 Million | $18.71 Million | ▼ -383.0% |
| 2020 | -0.39x | $-10.08 Million | $25.80 Million | ▼ -296.0% |
| 2019 | -0.10x | $-2.24 Million | $22.68 Million | — |